Abstract | OBJECTIVE: To review the pharmacology, pharmacokinetics, virology, safety, efficacy, and clinical use of fosamprenavir. DATA SOURCES: STUDY SELECTION AND DATA EXTRACTION: All publications, meeting abstracts, and unpublished information were reviewed and relevant items included. Information from in vitro, preclinical, and Phase II and III clinical trials was included. DATA SYNTHESIS: CONCLUSIONS:
|
Authors | E Kelly Hester, Haley V Chandler, Kelli M Sims |
Journal | The Annals of pharmacotherapy
(Ann Pharmacother)
2006 Jul-Aug
Vol. 40
Issue 7-8
Pg. 1301-10
ISSN: 1060-0280 [Print] United States |
PMID | 16757678
(Publication Type: Journal Article, Review)
|
Chemical References |
- Carbamates
- Furans
- HIV Protease Inhibitors
- Organophosphates
- Sulfonamides
- fosamprenavir
|
Topics |
- Carbamates
(adverse effects, pharmacokinetics, therapeutic use)
- Clinical Trials as Topic
- Drug Interactions
- Drug Resistance, Viral
- Furans
- HIV Infections
(drug therapy, metabolism, virology)
- HIV Protease Inhibitors
(adverse effects, pharmacokinetics, therapeutic use)
- Humans
- Organophosphates
(adverse effects, pharmacokinetics, therapeutic use)
- Patient Compliance
- Sulfonamides
(adverse effects, pharmacokinetics, therapeutic use)
|